Phenobarbital
NDC Package 17856-0502-2
Package Information
Phenobarbital is a medication used alone or with other medications to control seizures. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-0502.
Identification & Billing
- RxCUI: 702519 - PHENobarbital 20 MG in 5 mL Oral Solution
- RxCUI: 702519 - phenobarbital 4 MG/ML Oral Solution
- RxCUI: 702519 - phenobarbital 20 MG per 5 ML Oral Solution
- RxCUI: 702519 - phenobarbital 30 MG per 7.5 ML Oral Solution
- RxCUI: 702519 - phenobarbital 60 MG per 15 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17856 - Atlantic Biologicals Corp.
- 17856-0502 - Phenobarbital
- 17856-0502-2 - 72 CUP, UNIT-DOSE in 1 CUP, UNIT-DOSE / 7.5 mL in 1 CUP, UNIT-DOSE
- 17856-0502 - Phenobarbital
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (17856-0502). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17856-0502-2 identifies a specific commercial package of 72 cup, unit-dose in 1 cup, unit-dose / 7.5 ml in 1 cup, unit-dose of Phenobarbital, labeled by Atlantic Biologicals Corp.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Atlantic Biologicals Corp. on April 04, 2019. The current certification is valid through December 31, 2022.
What are the primary indications for this medication?
This medication is used alone or with other medications to control seizures. Controlling and reducing seizures lets you do more of your normal daily activities, reduces your risk of harm when you lose consciousness, and lessens your risk for a possibly life-threatening condition of frequent, repeated seizures. Phenobarbital belongs to a class of drugs known as barbiturate anticonvulsants/hypnotics. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure. This medication is also used for a short time (usually no more than 2 weeks) to help calm you or help you sleep during periods of anxiety. It works by affecting certain parts of the brain to cause calming.
How is this Atlantic Biologicals Corp. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856050202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.